Drug Safety Oversight Efforts Paying Off, CDER’s Galson Says
This article was originally published in The Pink Sheet Daily
Executive Summary
The agency has held 29 advisory committee meetings on drug safety since February 2005, according to the CDER director.
You may also be interested in...
FDA Should Consider Ethicist For Drug Safety Oversight Board, Science Board Chair Says
An ethicist could provide input on risk/benefit issues on behalf of the public, UT’s Shine suggests.
FDA Drug Safety Oversight Board Will Include VA, Other Agencies
The panel is the primary feature of FDA's proposal to reform drug safety review within the agency; other features include the creation of a drug safety website. The panel and website are intended to increase drug safety "oversight" and "openness" at FDA.
NEJM, JAMA Editorials Give Opposing Opinions Of Mandatory HPV Vaccination
Two of the leading medical journals are offering opposing viewpoints on mandatory human papilloma virus vaccination, with experts contributing perspective pieces that directly reflect the larger political and social division over the issue